A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity.

England, Christopher G; Ng, Chin F; van Berkel, Victor; Frieboes, Hermann B

England, Christopher G; Ng, Chin F; van Berkel, Victor; Frieboes, Hermann B.

Affiliation

Frieboes HB; Department of Bioengineering, Lutz Hall 419, University of Louisville, Louisville, KY 40292, USA. hbfrie01@louisville.edu.

Curr Drug Targets ; 16(10): 1057-87, 2015.

Article in En | MEDLINE | ID: mdl-25944016

Subject(s)

Antineoplastic Agents/therapeutic use; Drug Carriers/chemistry; Lung Neoplasms/drug therapy; Nanomedicine; Nanoparticles/chemistry; Antineoplastic Agents/administration & dosage; Antineoplastic Agents/chemistry; Antineoplastic Agents/toxicity; Drug Carriers/toxicity; Humans; Lung Neoplasms/epidemiology; Lung Neoplasms/etiology; Lung Neoplasms/pathology; Nanoparticles/toxicity; Solubility; Tumor Microenvironment/drug effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Drug Carriers / Nanomedicine / Nanoparticles / Lung Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Curr Drug Targets Journal subject: TERAPIA POR MEDICAMENTOS Year: 2015 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links